San Francisco, California, November 07, 2017: Clinically relevant information is highly essential for a dedicated laboratory to function at its full capacity. Because point of care diagnostics offer the same, their demand has picked significant pace over the last few years. In a report, titled “Point Of Care Diagnostics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” TMR research offers a comprehensive analysis of the market discussing in detail various factors enabling growth in the global point of care diagnostics market. The report is intended at helping the stakeholders gain a better perspective of the market and new entrants gauge investment feasibility.
Technological advancements in various microfluidic diagnostic platforms have improved performance and functionality. This in turn has enabled the global point of care diagnostics market gain considerable momentum. Also recent advances such as multiplexing of samples, development of novel networking technologies, and miniaturization have resulted in the evolution of cutting-edge point-of-care diagnostics. These advances and activities have also led to innovation of devices with higher sensitivity and specificity in turn boosting patient outcome in various clinical settings. Furthermore, these advances have upped the availability of diagnostics and helped reducing the overall expenditure incurred on healthcare. Considering latest innovations in the field, the global point of care diagnostics market is geared to showcase an impressive growth in the coming years. Its prospects seem favorable especially in areas such as critical care, space travel, and veterinary medicines.
In order to check the clinical viability and technical feasibility of point of care diagnostics, intensive researches are conducted over the past few years. For instance, researches are conducted using saliva in cases of periodontitis. Also it is important to note saliva, which makes an important source of biomarkers, is already tested for applications in bedside testing. While technical feasibility of these tests are proven, a few hurdles still remain in their clinical applications.
Besides analyzing various factors influencing trends prevailing in the global point of care diagnostics market, the report segments it based on various criteria. Regionally, Europe, Asia Pacific, North America, and Rest of the World make the key segments in the global market. Of these regions, doing business in North America has proven quite lucrative for the market players. The region is witnessing an increasing prevalence of lifestyle-related diseases. Besides this, government initiatives are encouraging the advent of novel healthcare products, resulting in an increasing number of product approvals in the region.
Meanwhile, the point of care diagnostics market in Asia Pacific is forecast to show robust growth in the coming years. The improving healthcare infrastructure in the region, besides expanding pool of patient population has created an environment conducive to the market’s growth. Furthermore, initiatives by governments to strengthen their healthcare infrastructure are supporting the point of care diagnostics market’s growth across various nations in Asia Pacific. On the back of these factors, the prevalence of high unmet medical needs, and the rising willingness among patients to spend on advanced healthcare will give impetus to the point of care diagnostics market in Asia Pacific.
Some of the prominent companies operating in the global point of care diagnostics market are Beckman Coulter Inc., Siemens AG, Roche Diagnostics Limited, Abbott Laboratories Inc., Alere Inc., Becton, Dickinson and Company, and Johnson & Johnson.
Get Sample Copy of this Report